Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Lyerly

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Archives of Biochemistry and Biophysics|January 1, 1993
Purification and characterization of Clostridium difficile glutamate dehydrogenaseB M Anderson, C D Anderson, R L Van Tassell, et al.
The Journal of Hospital Infection|September 18, 2014
Clostridium difficile ribotype 027 is most prevalent among inpatients admitted from long-term care facilitiesL R Archbald-Pannone, J H Boone, R J Carman, et al.
Biochemical and Biophysical Research Communications|July 16, 1996
Effect of Clostridium difficile toxin B on IgE receptor-mediated signal transduction in rat basophilic leukemia cells: inhibition of phospholipase D activationK Ojio, Y Banno, S Nakashima, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 1, 1989
Clostridium difficile toxin A. Interactions with mucus and early sequential histopathologic effects in rabbit small intestineA A Lima, D J Innes, K Chadee, et al.
Toxicon : Official Journal of the International Society on Toxinology|February 1, 1993
Production of monoclonal antibodies against Clostridium difficile cytotoxin using immunosorbent binding bioassay procedureC Depitre, R M L'Haridon, D M Lyerly, et al.
Infection and Immunity|March 18, 2000
Clostridium difficile recombinant toxin A repeating units as a carrier protein for conjugate vaccines: studies of pneumococcal type 14, Escherichia coli K1, and Shigella flexneri type 2a polysaccharides in miceD Pavliakova, J S Moncrief, D M Lyerly, et al.
Cancer Research|September 15, 1992
Cytotoxicity of Clostridium difficile toxin A for human colonic and pancreatic carcinoma cell linesV M Kushnaryov, P N Redlich, J J Sedmak, et al.
Infection and Immunity|July 1, 1993
Purification and characterization of alpha-toxin produced by Clostridium novyi type AD W Ball, R L Van Tassell, M D Roberts, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|March 1, 1994
Vascular and glomerular effects of Clostridium difficile toxin A peptide on the isolated rat kidneyH S Monteiro, M S Santos-Neto, A V Oliveira, et al.
Toxicon : Official Journal of the International Society on Toxinology|May 1, 1997
Role of tumor necrosis factor and nitric oxide in the cytotoxic effects of Clostridium difficile toxin A and toxin B on macrophagesA A Melo Filho, M H Souza, D M Lyerly, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Archives of Biochemistry and Biophysics|January 1, 1993
Purification and characterization of Clostridium difficile glutamate dehydrogenaseB M Anderson, C D Anderson, R L Van Tassell, et al.
The Journal of Hospital Infection|September 18, 2014
Clostridium difficile ribotype 027 is most prevalent among inpatients admitted from long-term care facilitiesL R Archbald-Pannone, J H Boone, R J Carman, et al.
Biochemical and Biophysical Research Communications|July 16, 1996
Effect of Clostridium difficile toxin B on IgE receptor-mediated signal transduction in rat basophilic leukemia cells: inhibition of phospholipase D activationK Ojio, Y Banno, S Nakashima, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 1, 1989
Clostridium difficile toxin A. Interactions with mucus and early sequential histopathologic effects in rabbit small intestineA A Lima, D J Innes, K Chadee, et al.
Toxicon : Official Journal of the International Society on Toxinology|February 1, 1993
Production of monoclonal antibodies against Clostridium difficile cytotoxin using immunosorbent binding bioassay procedureC Depitre, R M L'Haridon, D M Lyerly, et al.
Infection and Immunity|March 18, 2000
Clostridium difficile recombinant toxin A repeating units as a carrier protein for conjugate vaccines: studies of pneumococcal type 14, Escherichia coli K1, and Shigella flexneri type 2a polysaccharides in miceD Pavliakova, J S Moncrief, D M Lyerly, et al.
Cancer Research|September 15, 1992
Cytotoxicity of Clostridium difficile toxin A for human colonic and pancreatic carcinoma cell linesV M Kushnaryov, P N Redlich, J J Sedmak, et al.
Infection and Immunity|July 1, 1993
Purification and characterization of alpha-toxin produced by Clostridium novyi type AD W Ball, R L Van Tassell, M D Roberts, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|March 1, 1994
Vascular and glomerular effects of Clostridium difficile toxin A peptide on the isolated rat kidneyH S Monteiro, M S Santos-Neto, A V Oliveira, et al.
Toxicon : Official Journal of the International Society on Toxinology|May 1, 1997
Role of tumor necrosis factor and nitric oxide in the cytotoxic effects of Clostridium difficile toxin A and toxin B on macrophagesA A Melo Filho, M H Souza, D M Lyerly, et al.
Pageof 6